Needham analyst David Saxon has maintained their neutral stance on ALGN stock, giving a Hold rating today.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
David Saxon has given his Hold rating due to a combination of factors impacting Align Tech’s performance. The company’s second-quarter revenue for 2025 fell short of expectations, primarily due to a decline in clear aligner volumes and revenue per case. This shortfall is attributed to the macroeconomic uncertainty affecting orthodontic case starts and a market shift towards traditional brackets and wires.
Despite the challenges, Align Tech has implemented cost reduction measures to uphold its operating margin guidance for 2025 and aims for further expansion in 2026. However, Saxon expresses skepticism about the anticipated sales improvement in the fourth quarter of 2025, as outlined in the company’s guidance, and sees potential downside risks to Align Tech’s long-range plan. These uncertainties contribute to the decision to maintain a Hold rating on the stock.
Saxon covers the Healthcare sector, focusing on stocks such as Cooper Co, DENTSPLY SIRONA, and Align Tech. According to TipRanks, Saxon has an average return of -1.8% and a 35.92% success rate on recommended stocks.
In another report released today, Morgan Stanley also downgraded the stock to a Hold with a $154.00 price target.